Jen Jen Yeh Archives - UNC Lineberger Comprehensive Cancer Center

July 9, 2026

WebMD: How to Be Sure Your Pancreatic Cancer Is Inoperable

Headshots of Jen Jen Yeh and Joseph DeSimone

A precision drug delivery technology with roots at UNC-Chapel Hill has launched a first-in-human phase I clinical trial of its iontophoretic oncology platform (IOP) for pancreatic cancer, now open for enrollment.

Headshots of Channing Der and Jen Jen Yeh

Channing J. Der, PhD, and Jen Jen Yeh, MD, published an editorial contextualizing a landmark clinical study evaluating daraxonrasib, a first-in-class drug targeting KRAS-mutant metastatic pancreatic ductal adenocarcinoma (PDAC).

AACR (American Association for Cancer Research) Annual Meeting 2025 Chicago.

Nearly 30 UNC Lineberger and UNC faculty and trainees will present findings and participate during the American Association for Cancer Research annual meeting in Chicago, April 25-30.

Group photo of approximately 60 people who attended the 2025 GI SPORE Investigators Meeting in Chapel Hill.

The nation’s top gastrointestinal cancer clinical translational researchers convened in Chapel Hill for the 2025 GI SPORE Investigators Meeting.

Headshots of Jonathan Serody and Jen Jen Yeh.

Jonathan Serody, MD, and Jen Jen Yeh, MD, were named the 2023 recipients of the Hyman L. Battle Distinguished Cancer Research Award, recognizing their significant scientific achievements.

Naim Rashid, PhD, has received a Department of Defense Pancreatic Cancer Research Program pilot award to build an AI tool that generates personalized clinical trial recommendations for patients with PDAC.

Exteriors of the UNC Lineberger and Marsico Hall buildings.

More than $1.3 million in UNC Lineberger developmental research grants were awarded to 13 faculty members and one postdoctoral trainee this spring.

Tag: Jen Jen Yeh

WebMD: How to Be Sure Your Pancreatic Cancer Is Inoperable

Drug delivery technology developed by UNC researchers enters first-in-human clinical trial for pancreatic cancer

OncLive: From Discovery to Patient Care: Vitamin D Analog Shuts Down Pancreatic Cancer’s Shield in Clinical Trial

Yahoo! Finance: Continuity Biosciences Announces First-in-Human Clinical Trial of Precision Drug Delivery Platform for Pancreatic Cancer

Der, Yeh provide scientific context for recent progress in RAS therapeutics for pancreatic cancer

UNC Lineberger and UNC faculty and trainees present findings at AACR annual meeting

UNC Lineberger hosts NCI in gastrointestinal cancer SPORE Investigators Meeting

Serody and Yeh honored with Battle Distinguished Cancer Research Award

Rashid awarded grant to develop AI tool that recommends optimal clinical trials to pancreatic cancer patients

UNC Lineberger provides $1.3 million in developmental research grants